Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Genes, Chromosomes & Cancer|November 13, 2025
Primary Sweat Gland Adenocarcinoma of the Skin With ATL2::PRKD3 Fusion: A Potential Cutaneous Analog of Cribriform Adenocarcinoma of the Salivary Glands?Anaïs Brunet, Barouyr Baroudjian, Maxence Mancini, et al.
JPRAS Open|March 30, 2026
Reflectance confocal microscopy in the management of lentigo maligna and lentigo maligna melanoma: a systematic reviewOlivier Mathieu, Douglas Henderson, Emilien Ezine, et al.
Virchows Archiv : an International Journal of Pathology|May 20, 2021
Clinicopathologic and molecular characterization of melanomas mutated for CTNNB1 and MAPKBénédicte Oulès, Samia Mourah, Barouyr Baroudjian, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|October 9, 2025
Impact of reflectance confocal microscopy on surgical outcomes in lentigo maligna and lentigo maligna melanoma: A retrospective cohort study of 282 patientsOlivier Mathieu, Barouyr Baroudjian, Yannick Sprunger, et al.
Annales De Pathologie|February 29, 2020
[An unusual digestive complication under anti-PD-1 (pembrolizumab)]Julien Calvani, Rémie Elia, Maxime Battistella, et al.
Cancers|July 9, 2022
18FDG PET Assessment of Therapeutic Response in Patients with Advanced or Metastatic Melanoma Treated with First-Line Immune Checkpoint InhibitorsAlexia Rivas, Julie Delyon, Antoine Martineau, et al.
Chest|May 10, 2016
Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With Advanced MelanomaFrançois-Xavier Danlos, Cécile Pagès, Barouyr Baroudjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2022
Phase I Study of Androgen Deprivation Therapy in Combination with Anti-PD-1 in Melanoma Patients Pretreated with Anti-PD-1Caroline Robert, Céleste Lebbé, Thierry Lesimple, et al.
Melanoma Research|March 19, 2016
Anti-PD1-induced collagenous colitis in a melanoma patientBarouyr Baroudjian, Nelson Lourenco, Cécile Pagès, et al.
Seminars in Arthritis and Rheumatism|April 26, 2017
Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumabMarie-Léa Gauci, Barouyr Baroudjian, Pauline Laly, et al.
Pageof 6